An endometrial biopsy is a small tissue sample that is obtained from the inner wall of the uterus (the endometrium). This sample can then be analyzed in the laboratory, using massive sequencing technology, to determine a woman’s unique personalized embryo transfer timing. This allows for the synchronization of an implanting embryo with the individualized window of implantation (WOI).
Endometrial Receptivity Analysis (ERA) Test
The ERA Test, developed by IGENOMIX, analyzes an endometrial biopsy, determining the best time to carry out an embryo transfer to increase the chances of implantation and pregnancy.
To do this, we analyze 248 genes that tell us if the endometrium is receptive or not at the time the biopsy was taken. Based on the results we will understand if the WOI has been detected or if it is displaced.
After studying more than 50,000 samples, we have been able to refine the algorithm of the Igenomix ERA test to the point where we are able to predict where the implantation window is in >90% of cases, omitting the need for a second biopsy.
Is ERA for you?
Considering that 3 out of 10 women have a displaced implantation window, the ERA Test by IGENOMIX is indicated for all patients starting assisted reproductive treatments and has the greatest benefit for those who have experienced repeated implantation failures (2 or more failed attempts at in vitro fertilization or a failure with donor eggs).